Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1998
10/15/1998CA2284922A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/15/1998CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor
10/14/1998EP0870831A1 Histidine kinase polypeptides
10/14/1998EP0870829A2 Staphylococcus aureus cell division gene Div1B
10/14/1998EP0870828A1 NOVEL POLYPEPTIDE ORIGINATING IN $i(HEMOPHILUS PARAGALLINARUM) AND PROCESS FOR PRODUCING THE SAME
10/14/1998EP0870827A2 Tumor necrosis factor related receptor, TR6
10/14/1998EP0870825A1 Human protein kinases hYAK3
10/14/1998EP0870508A1 Influenza vaccine
10/14/1998EP0870046A1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
10/14/1998EP0870034A1 Novel nagpu
10/14/1998EP0870033A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
10/14/1998EP0870026A1 Ob protein derivatives having prolonged half-life
10/14/1998EP0870024A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/14/1998EP0870022A1 Immunostimulatory composition and method
10/14/1998EP0870011A1 Salmonella vaccines
10/14/1998EP0869971A1 Two component signal transducing system protein from staphylococcus aureus
10/14/1998EP0869970A1 Endothelial cell proliferation inhibitor and method of use
10/14/1998EP0869818A1 Cytotoxic agents
10/14/1998EP0869816A1 Dry compositions
10/14/1998EP0869815A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells
10/14/1998EP0869814A1 Stabilisers for live vaccines
10/14/1998EP0869804A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
10/14/1998EP0869803A1 Allogeneic paracrine cytokine tumor vaccines
10/14/1998EP0869802A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions
10/14/1998EP0869801A2 Therapeutic and diagnostic agents for the treatment of microbial infections
10/14/1998EP0869773A1 Archaeosomes, archaeosomes containing coenzyme q 10?, and other types of liposomes containing coenzyme q 10? as adjuvants and as delivery vehicles
10/14/1998EP0769932B1 Implanted device containing tumor cells for the treatment of cancer
10/14/1998EP0764273B1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
10/14/1998EP0687271B1 Extraction of cell-bound protein from bordetella
10/14/1998EP0665887B1 Human 5-ht 2? receptor
10/14/1998EP0628054B1 Car receptors and related molecules and methods
10/14/1998EP0446273B1 Monoclonal antibodies to feline-t-lymphotropic lentivirus
10/14/1998CN1196089A DNA polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis
10/14/1998CN1195993A Intranasal vaccination against gastrointestinal disease
10/14/1998CN1195982A Fgfr 3 as marker for mesenchymal skelftal progenitor cells
10/14/1998CN1195701A Antihumanfibrin monoclonal antibody heavy chain and light chain variable region gene and its application
10/14/1998CN1195667A Novel antibody, renin-active substance containing same and prorenin assay reagent using the same
10/14/1998CN1040212C Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions
10/14/1998CN1040178C Complement inhibitor for preparing drug for promoting transplantation survival or eliminating rejection
10/13/1998US5821342 Carbamazepine derivatives/antigens
10/13/1998US5821337 Immunoglobulin variants
10/13/1998US5821336 Polypeptide having specified amino acid sequence or fragment thereof
10/13/1998US5821333 Method for making heteromultimeric polypeptides
10/13/1998US5821332 Isolated receptor polypeptide having specified amino acid sequence; modulating immune response
10/13/1998US5821238 Administering to patient to impair tumor growth
10/13/1998US5821224 Purified beta-defensin with consensus sequence having net positive charge that lacks three consecutive basic amino acids at the carboxyl terminus; polyclonal and monoclonal antibodies and drugs
10/13/1998US5821124 Hybridoma cell lines and antibodies that bind noggin
10/13/1998US5821123 Modified antibody variable domains
10/13/1998US5821122 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
10/13/1998US5821117 Porcine cell comprising alpa-1,3 galactosyl transferase
10/13/1998US5821088 Use of gram-positive bacteria to express recombinant proteins
10/13/1998US5821087 Transforming a saccharomyces cerevisiae yeast cell with an expression vector comprising a papillomavirus 6/11 hybrid dna encoding l1 protein to produce transformed yeast
10/13/1998US5821085 Culturing; isolation; antigenic
10/13/1998US5821070 Antibodies reactive with retinoblastoma binding proteins and methods of using same
10/13/1998US5821067 Mammalian methadone-specific opioid receptor and uses in binding assays
10/13/1998US5821065 Immunoassay for the detection of collagen I
10/13/1998US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte
10/13/1998US5821051 Combining e6 protein, e6 binding protein, and test compound,detecting formation of complex; identifying agents which affect protein binding; human papillomavirus
10/13/1998US5820880 Adding a nonionic detergent to avoid instability in the presence of alum
10/13/1998US5820872 Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
10/13/1998US5820871 Influenza virus, due to its genetic variability, stimulates immunity without developing a tolerance
10/13/1998US5820870 Recombinant human papillomavirus type 18 vaccine
10/13/1998US5820869 Gene comprising dna sequence encoding the envelope protein
10/13/1998US5820866 Product and process for T cell regulation
10/13/1998US5820865 Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides
10/13/1998US5820863 A non-naturally occuring non-rodent zona pellucida polypeptide which is the expression product of dna encoding a mammalian zona pellucia polypeptide having immunological cross-reactivity with zona pellucida protein encoded by dna
10/13/1998US5820862 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
10/13/1998US5820861 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
10/13/1998US5820859 Administering a drug congugated to an antibody specific for the extracellular domain of gp180(erbb-3), which will not bind to erbb-2 or erbb; human mammary tumor line targeting
10/13/1998US5820858 Methods and compositions for inhibiting CD14 mediated cell activation
10/13/1998CA1340082C Bovine interleukin-10c
10/13/1998CA1340080C Human tumor therapy
10/10/1998CA2233524A1 Novel compounds
10/10/1998CA2228719A1 Live attenuated bacteria of the species actinobacillus pleuropneumoniae
10/09/1998CA2234472A1 Vaccines
10/08/1998WO1998044143A1 Polymer-modified viruses
10/08/1998WO1998044133A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
10/08/1998WO1998044130A1 RECOMBINANT MICROORGANISMS EXPRESSING ANTIGENIC PROTEINS OF $i(HELICOBACTER PYLORI)
10/08/1998WO1998044129A1 Enhancement of immune response using targeting molecules
10/08/1998WO1998044128A1 Novel human serine carboxypeptidase
10/08/1998WO1998044122A1 Method for producing non-infectious recombinant picornavirus particles
10/08/1998WO1998044121A1 Modified adenoviral fiber and target adenoviruses
10/08/1998WO1998044119A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
10/08/1998WO1998044096A2 Mycobacterium recombinant vaccines
10/08/1998WO1998044094A2 Helicobacter aliphatic amidase polypeptides, dna sequences encoding those polypeptides and uses thereof
10/08/1998WO1998044093A1 Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient
10/08/1998WO1998044001A1 High avidity polyvalent and polyspecific reagents
10/08/1998WO1998043702A2 Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
10/08/1998WO1998043694A1 Targeted therapy to a biomedical device
10/08/1998WO1998043677A1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
10/08/1998WO1998043670A2 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a
10/08/1998WO1998043669A1 Chimeric viral proteins
10/08/1998WO1998043668A1 Attenuated respiratory syncytial virus
10/08/1998WO1998043667A1 Methods and compositions for treating inflammatory bowel disease
10/08/1998WO1998043657A2 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same
10/08/1998WO1998043482A1 Fibrocyte-based cellular therapy formulations
10/08/1998WO1998043479A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES
10/08/1998WO1998043478A1 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/08/1998WO1998018930A3 Streptococcus pneumoniae antigens and vaccines
10/08/1998WO1998016646A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis